Webinar
Will Predictive Planning Drive the Future of Personalized Care?
Mass Personalization Summit 2022
About this webinar
Watch the recording of this panel discussion to learn about the future of predictive planning from industry leaders.
What you will learn
- If AI will replace humans when it comes to procedural planning in ten years
- What we can learn from clinical fields where 3D planning has become the norm
- If in the future predictive planning will mostly be performed at medical device companies or in the hospital by clinicians
Speakers
Saravana Kumar
Vice President of R&D and Operations, 4C Medical Technologies
Saravana Kumar is currently Vice President of R&D and Operations at 4C Medical Technologies, a company developing an innovative solution for the treatment of mitral valve regurgitation. Prior to 4C Medical, Saravana served as Senior Director of R&D and Operations at Conventus Orthopaedics, and led engineering teams at St. Jude Medical for the successful development and commercialization of a transcatheter aortic valve replacement technology. Saravana received his PhD in Mechanical Engineering from the University of Minnesota, his master’s degree from the University of North Carolina, and his bachelor’s degree from the University of Delhi in India.
Saravana Kumar
Vice President of R&D and Operations, 4C Medical Technologies
Saravana Kumar is currently Vice President of R&D and Operations at 4C Medical Technologies, a company developing an innovative solution for the treatment of mitral valve regurgitation. Prior to 4C Medical, Saravana served as Senior Director of R&D and Operations at Conventus Orthopaedics, and led engineering teams at St. Jude Medical for the successful development and commercialization of a transcatheter aortic valve replacement technology. Saravana received his PhD in Mechanical Engineering from the University of Minnesota, his master’s degree from the University of North Carolina, and his bachelor’s degree from the University of Delhi in India.
Zihe Zhou
Zhenyuan (Zealise) Medical
Zihe Zhou
Zhenyuan (Zealise) Medical
Pras Pathmanathan
Senior Research Scientist, FDA
As a Research Scientist at the FDA specializing in the computational modeling of complex physiological systems with a focus on models of the heart, Pras is an expert in the assessment of computational models. Much of his current work regards the development of computational models — together with methods to ensure that model predictions can be trusted — that will allow computational models to be broadly used across medicine, such as in the optimization of medical devices and drugs, simulation-based diagnosis, and therapy. He co-founded and is co-chair of the FDA-wide Modeling and Simulation Working Group, which is made up of nearly 200 scientists across the Agency.
Pras Pathmanathan
Senior Research Scientist, FDA
As a Research Scientist at the FDA specializing in the computational modeling of complex physiological systems with a focus on models of the heart, Pras is an expert in the assessment of computational models. Much of his current work regards the development of computational models — together with methods to ensure that model predictions can be trusted — that will allow computational models to be broadly used across medicine, such as in the optimization of medical devices and drugs, simulation-based diagnosis, and therapy. He co-founded and is co-chair of the FDA-wide Modeling and Simulation Working Group, which is made up of nearly 200 scientists across the Agency.
Share on:
L-103119-01
Mass Personalization Summit 2022
One size fits no one. That’s why mass personalization is crucial to ensure predictable and efficient patient care. Watch recordings from our virtual event to learn how together we can make personalization scalable for a more sustainable future in healthcare.
